Skip to main content

Month: August 2021

Dominion Lending Centres Inc. Announces Q2-2021 Earnings Release Date

VANCOUVER, British Columbia, Aug. 11, 2021 (GLOBE NEWSWIRE) — Dominion Lending Centres Inc. (TSXV:DLCG) (“DLCG” or the “Corporation”) is pleased to announce that it will release its financial results for the three and six months ended June 30, 2021, on August 23, 2021, after the market close. About Dominion Lending Centres Inc. The DLC Group is Canada’s leading network of mortgage professionals. The DLC Group operates through Dominion Lending Centres and its three main subsidiaries, MCC Mortgage Centre Canada Inc., MA Mortgage Architects Inc. and Newton Connectivity Systems Inc., and has operations across Canada. The DLC Group’s extensive network includes ~7,000 agents and 515 locations. Headquartered in British Columbia, the DLC Group was founded in 2006 by Gary Mauris and Chris Kayat. Contact information for the Corporation is...

Continue reading

Brookfield Infrastructure Reminds Inter Pipeline Shareholders to Tender to the Board Recommended Offer – Offer Open Until August 20th at 5 p.m. (Mountain Time)

Inter Pipeline Ltd. (“IPL”) shareholders who tender to the Offer will remain eligible to receive IPL’s August cash dividend1 IPL shareholders must tender their shares by August 20th to receive the significant premium available under Brookfield Infrastructure’s Offer IPL shareholders that have already tendered do not need to take any further action Given the 52% initial tender results and tenders that continue to be received, Brookfield Infrastructure is confident the modified statutory minimum condition will be met Questions or Need Assistance? Contact Laurel Hill Advisory Group at 1-877-452-7184 or email assistance@laurelhill.comBROOKFIELD, News, Aug. 11, 2021 (GLOBE NEWSWIRE) — Brookfield Infrastructure Partners L.P. (NYSE: BIP; TSX: BIP.UN), together with its institutional partners (collectively, “Brookfield Infrastructure”)...

Continue reading

H1 2021 Interim Financial Report: solid demand across all markets led to strong organic growth and historical high earnings

Today, the Board of Directors of H+H International A/S (hereinafter referred to as “H+H” or “the Group”) has adopted the Interim Financial Report for the first half of 2021 (“H1 2021”). CEO Michael T. Andersen quote “Our markets have quickly recovered from the slowdown seen in early in the year caused by harsh weather conditions and Q2 2021 has showed solid demand across all markets leading to strong organic growth and historical high earnings for H+H—both for the quarter and for the half-year period. The UK market in particular has showed very strong demand and H+H is producing at near-full capacity to service its customers. Germany continues to provide a strong and stable market for H+H and in Poland, increasing demand appears to have stabilised the competitive situation in the CSU business and price increases have been observed in certain...

Continue reading

Ultimovacs ASA: Invitation to second quarter 2021 results webcast presentation

Oslo, 11 August 2021: Ultimovacs ASA (“Ultimovacs”) (OSE ULTI), a clinical stage leader in immune stimulatory vaccines for cancer, invites to a webcast presentation of its second quarter 2021 results on Friday 20 August 2021. The presentation can be followed as a live webcast (access through link https://channel.royalcast.com/hegnarmedia/#!/hegnarmedia/20210820_5) at 09:00 CET on Friday 20 August 2021. The webcast presentation will be available on the Ultimovacs website, and it will be possible to post questions during the presentation through the webcast. The report and presentation will be available on the company website from 08:00 CET the same day. For further information, please see www.ultimovacs.com or contact: Carlos de Sousa, CEO Email: carlos.desousa@ultimovacs.comPhone: +47 908 92507 Hans Vassgård Eid, CFO Email: hans.eid@ultimovacs.comPhone:...

Continue reading

Brunswick Corporation Announces Expiration of Any and All Tender Offers

METTAWA, Ill., Aug. 11, 2021 (GLOBE NEWSWIRE) — Brunswick Corporation (NYSE: BC) (“Brunswick”) today announced the expiration of its previously announced tender offers (the “Tender Offers”) to purchase for cash any and all of its outstanding 7.375% Debentures due 2023 (the “7.375% Debentures”) and 7.125% Notes due 2027 (the “7.125% Notes” and, together with the 7.375% Debentures, the “Securities”). The following table sets forth specified terms of the Tender Offers:Title of Security Security Identifiers Principal Amount Outstanding Reference U.S. Treasury Security Principal Amount Tendered (percent of Principal Amount Outstanding)(1)7.375% Debentures due 2023 CUSIP: 117043AE9 ISIN: US117043AE96 $ 103,071,000 0.125% UST due 07/31/2023 $23,370,000 (22.67%)7.125% Notes due 2027 CUSIP: 117043AG4 ISIN: US117043AG45 $ 163,265,000 0.625%...

Continue reading

OTC: ILUS, ILUS International (Ilustrato Pictures International Inc) Acquisition BCD Fire Secures Three New Contracts in the Third Quarter of 2021, Valued at Over $1.5 Million

NEW YORK, NY, Aug. 11, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — ILUS International Inc (OTC: ILUS) is a M&A company focused on acquiring and developing technology-based companies globally. The company has already completed three acquisitions in 2021, including that of BCD Fire, on April 12th. ILUS has also recently signed two Letters of Intent for the acquisition of two US companies. In addition to BCD Fire, which supplies, installs, and maintains fixed fire systems and life safety equipment in the Middle East, ILUS is also currently assessing the acquisition of another fixed fire system company in the United States.  Located in Dubai, United Arab Emirates and founded in 2014, BCD Fire is a leading systems integrator for fire and life safety systems in the region and is certified by Dubai Civil Defence. The company...

Continue reading

Notice to extraordinary general meeting in Konsolidator A/S

Company announcement no 11-2021 Søborg, August 11, 2021 Notice to extraordinary general meeting in Konsolidator A/S Notice is hereby given to shareholders in Konsolidator A/S of extraordinary general meeting scheduled for August 26, 2021, at 15:00. Enclosed please find notice and agenda for the extraordinary general meeting. AttachmentsNotice to extraordinary general meeting 2021 / Indkaldelse til ekstraordinær generalforsamling 2021 Ordering of admission card / Bestilling af adgangskort Proxy and postal vote form / Fuldmagt og brevstemmeCOVID-19 To minimize the risk of spreading COVID-19 and adhere to the latest recommendations from the Danish health authorities the board of directors recommends that the shareholders of Konsolidator do not attend the extraordinary general meeting in person, and instead vote in advance by postal vote...

Continue reading

BW Ideol: Invitation to first half 2021 presentation 19 August

BW Ideol AS will publish its financial results for the first half of 2021 on Thursday 19 August following the Board meeting held the same day. The half year report and presentation material will be available on the Company’s website at the same time. The Company will hold a live webcast presentation in connection with the first half report on the same day at 13:00 CEST. The webcast will be held in English by CEO Paul Dupin de la Guérivière and CFO Nicolas de Kerangal. The webcast will be available by following this link : https://bit.ly/3CHPe9o Alternatively, dial the following number: +47 21 40 42 22 (Phone Conference ID: 199 690 797#) For further information, please contact:Nicolas de Kerangal, Chief Financial & Partnerships Officer at BW Ideol, +33 (0) 7 76 87 70 08 ir@bw-ideol.com    About BW Ideol:BW Ideol is a leading...

Continue reading

Plus Therapeutics to Present Data from Two Studies Supporting the Treatment of Leptomeningeal Metastases with Rhenium-186 Nanoliposome

AUSTIN, Texas, Aug. 11, 2021 (GLOBE NEWSWIRE) — Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing innovative, targeted therapies for rare and difficult to treat cancers, today announced it will present data from one planned clinical trial and one completed preclinical study evaluating its lead investigational drug, Rhenium-186 Nanoliposome (186RNL), for the treatment of leptomeningeal metastases (LM). The data will be presented at the Third Annual Conference on Brain Metastases hosted by the Society for Neuro-Oncology (SNO), being held virtually August 19-20, 2021. Data from both studies will be presented as electronic posters (ePosters) by Andrew J. Brenner, M.D., Ph.D., Associate Professor of Medicine, Neurology, and Neurosurgery at The University of Texas, and principal...

Continue reading

E SPLIT CORP. Completes Overnight Offering of Over $63 Million     

TORONTO, Aug. 11, 2021 (GLOBE NEWSWIRE) — Middlefield Group, on behalf of E Split Corp. (TSX: ENS and ENS.PR.A) (the “Company”), is pleased to announce the Company has completed the overnight offering of class A and preferred shares (the “Class A Shares” and “Preferred Shares”, respectively) for aggregate gross proceeds of approximately $63.2 million. The Class A Shares and Preferred Shares will trade on the Toronto Stock Exchange under the existing symbols ENS (Class A Shares) and ENS.PR.A (Preferred Shares). The Class A Shares were offered at a price of $14.50 per Class A Share to yield 10.8% and the Preferred Shares were offered at a price of $10.00 per Preferred Share to yield 5.3%. The Class A Share and Preferred Share offering prices were determined so as to be non-dilutive to the net asset value per unit of the Company on...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.